Barclays Hires Tyagi for Health-Care Investment Banking
(Bloomberg) -- Barclays Plc has hired Amit Tyagi as a managing director covering tools and diagnostics in its health-care investment banking group.
Tyagi will be based in New York and report to Rick Landgarten, the global head of Barclays’ health-care and real estate groups, according to a statement Tuesday.
He joins from Huatai Securities, where he ran the health-care group. He previously was global head of medical diagnostics and life sciences tools at UBS Group AG. Tyagi has also worked on the company side of health care as a senior project manager at Medline Industries.
“Amit’s appointment is further evidence of our commitment to investing in and operating a top-tier health-care franchise,” Landgarten said in the statement.
Tyagi has advised companies including Asahi Kasei Corp. on its acquisition of Zoll Medical and Zonare Medical Systems on its sale to Mindray, among others.
Barclays’ investment bankers advised on some of the year’s top health-care deals, including Thermo Fisher Scientific Inc.’s $17.4 billion acquisition of PPD Inc. and insurer Centene Corp.’s $2.2 billion acquisition of Magellan Health Inc.
©2021 Bloomberg L.P.